​
​

Revance Therapeutics Ownership | Who Owns Revance Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Revance Therapeutics Ownership Summary

Revance Therapeutics is owned by 88.55% institutional investors, 8.52% insiders, and 2.93% retail investors. Blackrock is the largest institutional shareholder, holding 9.32% of RVNC shares. American Funds SMALLCAP World A is the top mutual fund, with 7.09% of its assets in Revance Therapeutics shares.

RVNC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRevance Therapeutics88.55%8.52%2.93%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
American Funds SMALLCAP World A7.38M7.09%-
American Funds New Economy A6.33M6.08%-3.96K
Capital Group New Economy Comp6.33M6.08%-3.96K
Vanguard Total Stock Mkt Idx Inv3.09M2.95%-
iShares Russell 2000 ETF2.70M2.57%-6.08K
Franklin Biotechnology Discv A(acc)USD1.95M1.87%-1.20M
Franklin Small Cap Growth Adv1.52M1.46%-
Franklin US Small Cap Growth Equity1.52M1.46%-15.63K
Federated Hermes MDT SCC Institutional1.51M1.45%516.10K
Federated Hermes MDT Small Cap Core IS1.51M1.45%516.10K

Recent Insider Transactions

DateNameRoleActivityValue
Apr 16, 2024Jordan Erica Chief Commercial OfficerSell$9.10K
Mar 18, 2024Sjuts Dustin S PresidentSell$46.45K
Mar 18, 2024Moxie Dwight CLO & GCSell$40.97K
Mar 18, 2024Schilke Tobin CFOSell$47.20K
Mar 06, 2024Foley Mark J CEOBuy$209.40K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q2-1
2024 Q113
2023 Q4--
2023 Q3-5

RVNC Ownership FAQ

Who Owns Revance Therapeutics?

Revance Therapeutics shareholders are primarily institutional investors at 88.55%, followed by 8.52% insiders and 2.93% retail investors. The average institutional ownership in Revance Therapeutics's industry, Biotech Stocks , is 45.35%, which Revance Therapeutics exceeds.

Who owns the most shares of Revance Therapeutics?

Revance Therapeutics’s largest shareholders are Blackrock (8.57M shares, 9.32%), Franklin resources (6.26M shares, 6.81%), and Vanguard group (5.99M shares, 6.52%). Together, they hold 22.65% of Revance Therapeutics’s total shares outstanding.

Does Blackrock own Revance Therapeutics?

Yes, BlackRock owns 9.32% of Revance Therapeutics, totaling 8.57M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.01M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 17.13% change.

Who is Revance Therapeutics’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is Revance Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.57% of its assets in 2.8M Revance Therapeutics shares, valued at 7.2M$.

Who is the top mutual fund holder of Revance Therapeutics shares?

American Funds SMALLCAP World A is the top mutual fund holder of Revance Therapeutics shares, with 7.09% of its total shares outstanding invested in 7.38M Revance Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools